GLI1 is overexpressed in BCSCs characterized by CD44+/CD24- phenotype compared to other cancer cells (Liu et al., 2006) and is important for EMT and metastatic progression (Colavito et al., 2014; Riaz et al., 2018). This evidence concerns the gene GLI1 and cancer.